Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context

• Κύριοι συγγραφείς: Wu N (Συγγραφέας), Bhurke S (Συγγραφέας), Shah N (Συγγραφέας), Harrison DJ (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Dove Medical Press, 2015-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Ning Wu,1 Sharvari Bhurke,1 Neel Shah,2 David J Harrison2 1Health Economics and Epidemiology, Evidera, Lexington, MA, USA; 2Amgen Inc., Thousand Oaks, CA, USA Background: Several biologic medicines are available to treat rheumatoid arthritis (RA), and they differ in administration method (subcutaneo...